Medicamentos de actualidad = Drugs of today

• 

  Año 2003, Vol. 39, Número Extraordinario 11. Dedicado a: EUROPEAN INSTITUTE OF HEALTHCARE ONCOLOGY SYMPOSIUM "New Approaches in Cancer Research" (Suppl. C, November)

  • Monoclonal antibodies in human cancer

    H. Mellstedt

    págs. 1-16

    

  • Metastatic malignant melanoma

    J.B. Meric, O. Rixe, D. Khayat

    págs. 17-38

    

  • Metastatic renal cell cancer treatments

    Cora Nanette Sternberg

    págs. 39-59

    

  • The epidermal growth factor receptor pathway and its inhibition as anticancer therapy

    M.L. Janmaat, G. Giaccone

    págs. 61-80

    

  • Vascular endothelial growth factor and its inhibitors

    H.M.W. Verheul, H.M. Pinedo

    págs. 81-93

    

  • Modulation of death receptor pathways in oncology

    E.G.E. De Vries, T. Timmer, N.H. Mulder, C.M.M. Van Geelen, W.T.A. Van Der Graaf, D.C.J. Spierings, M.N. De Hooge, J.A. Gietema, S. De Jong

    págs. 95-109

    

  • Molecular defects in colorectal tumorigenesis

    S. Tejpar, Eric Van Cutsem

    págs. 111-118